ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: PUB315

Granulomatous Interstitial Nephritis Following Bacillus Calmette-Guérin (BCG) Therapy: A Case Report

Session Information

Category: Pathology and Lab Medicine

  • 1800 Pathology and Lab Medicine

Authors

  • Al Kawam, Lamees Monzer, American University of Beirut, Beirut, Lebanon
  • Hafez, Rayan Youssef, American University of Beirut, Beirut, Lebanon
  • KFoury, Hala M., American University of Beirut, Beirut, Lebanon
  • Abu-Alfa, Ali K., American University of Beirut, Beirut, Lebanon
Introduction

The development of renal granulomas is a rare complication following intravesical BCG therapy for urothelial carcinoma. This condition is associated with interstitial inflammation and fibrosis leading to impaired renal function. Renal granuloma formation may be linked to vesicoureteral reflux which is frequently observed following transurethral resection of bladder tumors, particularly when the tumor is situated close to the ureteral orifice.

Case Description

We report a case of a 62-year-old man with high-grade non-invasive papillary urothelial carcinoma who underwent TURBT and received 2 cycles of intravesical BCG therapy. Following treatment, he developed a progressively rising serum creatinine from baseline of 1.1-1.2 mg/dl to to1.9 mg/dl with spot proteinuria of 1.1 g/g. Kidney biopsy showed extensive granulomatous interstitial nephritis with focal necrosis and approximately 40% fibrosis (Figures 1, 2).

Discussion

This rare entity should be considered during BCG therapy especially if a rise in serum creatinine cannot be explained by urologic causes. Management is controversial and includes observation or treatment with antituberculous chemotherapy with or without corticosteroids.

Figure 1. A. (H&E x40). This photomicrograph shows extensive patchy granulomas noted in the interstitium with scattered multinucleated giant cells, lymphocytes, plasma cells and histiocytes. There are two foci of necrosis present in the granulomas.

B. (H&E x200). This photomicrograph shows a higher power view of the granulomas with inflammation.

Digital Object Identifier (DOI)